Last updated: April 28, 2024
Sponsor: Ulrich Rother
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Peripheral Arterial Occlusive Disease
Circulation Disorders
Treatment
MSOT
Clinical Study ID
NCT06391346
MSOT-gluteal
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Patient with gluteal claudication in Fontaine stage II and corresponding stenosis (commoniliac artery, internal iliac artery or distal aorta)
Exclusion
Exclusion Criteria:
- Patients with PAD in Fontaine stage I, III and IV or Rutherford category 0, 4, 5 and 6or healthy volunteers with diabetes mellitus, chronic renal failure, claudicationsymptoms, abnormal ABI or non-palpable foot pulses
- People with age under 18
- Absence of written consent
- Safety concerns of the study physician (person with physical, mental or psychiatricconditions which, by the judgement of the study physician, would compromise theperson's safety or the quality of the data, thereby rendering the person an ineligiblecandidate for the study
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: MSOT
Phase:
Study Start date:
June 23, 2023
Estimated Completion Date:
April 30, 2024
Study Description
Connect with a study center
University of Erlangen-Nuremberg (FAU), Department of Vascular Surgery
Erlangen, Bavaria 91054
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.